About Pfizer
What Pfizer is building
Technologies used at Pfizer
PythonCompany culture
Health
We innovate every day to make the world a healthier place.
Funding rounds
Company type
Pfizer news and updates
Pfizer, Inc. launches Phase 3 results for fidanacogene elaparvovec
Pfizer has announced positive Phase 3 results for fidanacogene elaparvovec, an experimental gene therapy for hemophilia B.
Dec 30, 2022 | geneonline.comPfizer, Inc. identified as competitor of CSL on Nov 1st 22'.
The positive results may allow Pfizer to compete with CSL Behring AG ’s Hemgenix that was approved in the US in November.
Dec 29, 2022 | bloomberg.comPfizer, Inc. is developing ORIC-533 in multiple myeloma
ORIC Pharmaceuticals ( ORIC ) was gaining 49% in value after saying it has entered into a collaboration with Pfizer ( PFE ) to develop ORIC-533 in multiple myeloma, a type of bone marrow cancer.
Dec 22, 2022 | nasdaq.comPfizer, Inc. is developing COVID-19 vaccine on Jan 1st 22'.
The Pfizer CEO received the $1 million Genesis Prize in January for his work in developing Pfizer’s COVID-19 vaccine.
Dec 21, 2022 | atlantajewishtimes.comPfizer, Inc. is developing vaccine known as VLA15
Pfizer and French company Valneva are developing the vaccine known as VLA15.
Dec 20, 2022 | newscentermaine.comPfizer, Inc. has issues with civil investigative demand from the U.S. Attorney’s Office related to alleged quality
Pfizer also received a civil investigative demand from the U.S. Attorney’s Office related to alleged quality issues involving the manufacture of auto-injectors at the Meridian site.
Dec 19, 2022 | outsourcing-pharma.comPfizer, Inc. launched patient charter on Dec 16th 21'.
Last year, Pfizer launched its patient charter that defined how they interact and assist patients across the country.
Dec 16, 2022 | livemint.comPfizer, Inc. is developing AI software that can detect cardiac amyloidosis
A startup launched out of the Mayo Clinic Platform is partnering with Pfizer to develop AI software that can detect cardiac amyloidosis in an electrocardiogram.
Dec 16, 2022 | healthleadersmedia.comMayo Clinic partners with Pfizer, Inc.
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, entered into a multiyear partnership with Pfizer to develop an AI-based tool for the early detection of cardiac amyloidosis.
Dec 15, 2022 | mobihealthnews.comPfizer, Inc. is developing artificial intelligence electrocardiogram algorithm
Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a multi-year agreement with Pfizer, Inc. for Anumana to develop an artificial intelligence electrocardiogram algorithm (AI-ECG) designed to enable the early suspicion of cardiac amyloidosis.
Dec 15, 2022 | yahoo.comPfizer, Inc. partners with Anumana Inc.
Pharmaceutical giant Pfizer has partnered with digital health company Anumana, a company founded in 2021 in collaboration with the Mayo Clinic Platform, to develop an artificial intelligence electrocardiogram algorithm used for the detection of cardiac amyloidosis.
Dec 15, 2022 | beckershospitalreview.comOn The Pulse Consultancy Ltd partners with Pfizer, Inc.
On The Pulse Consultancy Ltd has been collaborating closely with Pfizer on a new global grant initiative to help bridge the equity gap in therapeutic patient education for haemophilia, which launched in December.
Dec 15, 2022 | onthepulseconsultancy.comThe Mosaic Company partners with Pfizer, Inc.
Mosaic partnered with Pfizer to create an e-learning safety training that leverages materials, photographs, and videos from the necropsy laboratory and includes scenario-based knowledge checks with formative feedback to ensure learner comprehension and engagement.
Dec 14, 2022 | themosaiccompany.comPfizer, Inc. is developing Covid-19 treatment on Dec 9th 22'.
As current Covid-19 therapeutics lose their effectiveness against new coronavirus variants, Pfizer and biotech startup Clear Creek Bio are partnering to develop a new Covid-19 treatment to keep up with the constantly evolving virus.
Dec 9, 2022 | advisory.comPfizer, Inc. invests into assets : sterile injectable facility in the amount of $750M in Kalamazoo, Michigan, United States
Pfizer Inc. (NYSE: PFE) has unveiled plans to invest $750 million in its sterile injectable facility in Kalamazoo.
Dec 7, 2022 | rebusinessonline.comPfizer, Inc. is developing pediatric maternal respiratory syncytial virus vaccine and pediatric COVID-19 vaccines
Maldonado reports working with Pfizer on a pediatric maternal respiratory syncytial virus vaccine and pediatric COVID-19 vaccines; being on a data safety and monitoring board for meningococcal vaccine trials; and receiving grants from the NIH.
Dec 7, 2022 | healio.comPfizer, Inc. partners with Boehringer Ingelheim GmbH
US pharma company Pfizer (PFE: NYSE) and German pharma company Boehringer Ingelheim also benefit from the ruling.
Dec 7, 2022 | sharesmagazine.co.ukPfizer, Inc. recognized as leader in Stewardship
Pfizer ranked high in R&D, Responsible Manufacturing and Appropriate Access, and was named a leader in Stewardship.
Dec 7, 2022 | gulfnews.comPfizer, Inc. launches 16 new products
In the past 12 months, Pfizer launched 16 new products.
Dec 7, 2022 | amgreatness.comPfizer, Inc. invested into assets : manufacturing facility in the amount of $750M in Kalamazoo, Michigan, United States on Jan 1st 18'.
Since 2018, Pfizer has spent about $1.67 billion to scale up its western Michigan manufacturing facility.
Dec 5, 2022 | freep.comPfizer, Inc. received financing of $84M on Jan 1st 01'.
Pfizer has received $84 million in subsidies since 2001 in Michigan, according to the Good Jobs first subsidy tracker.
Dec 5, 2022 | thecentersquare.comPfizer, Inc. invested into assets : pharmaceutical facility in the amount of $750M in Michigan, United States on Dec 12th 22'.
(CBS DETROIT) - Pfizer announced on Monday it is investing $750 million to expand its Southwest Michigan pharmaceutical facility.
Dec 5, 2022 | cbsnews.comPfizer, Inc. invested into assets : modular aseptic processing facility in the amount of $465M in Michigan, United States on Jan 1st 18'.
Pfizer's latest investment in Michigan follows a $465 million investment in its modular aseptic processing facility there in 2018.
Dec 5, 2022 | fiercepharma.comPfizer, Inc. partners with Sickle Cell Disease, Inc.
Pfizer partners with the Sickle Cell Disease Association of America to advance education and awareness of sickle cell disease.
Dec 2, 2022 | prweb.comPfizer, Inc. invests into Carrick Therapeutics in $35M
Carrick Therapeutics, a Dublin-headquartered biopharma firm, has landed a $35 million investment from Pfizer as it also confirmed the final closure of a $25 million Series C funding round.
Dec 1, 2022 | businesspost.iePfizer, Inc. launched RVT-3101 on Dec 8th 22'.
Roivant Sciences (ROIV.O) and Pfizer Inc (PFE.N) on Thursday announced the launch of a unit to develop RVT-3101, the drugmakers’ treatment for an inflammatory bowel disease.
Dec 1, 2022 | pharmalive.comPfizer, Inc. is developing RVT-3101 on Dec 8th 22'.
Roivant Sciences and Pfizer Inc on Thursday announced the creation of a new unit to develop RVT-3101, the drugmakers’ treatment for ulcerative colitis.
Dec 1, 2022 | wkzo.comPfizer, Inc. is developing PF-06480605 on Dec 1st 22'.
Roivant Sciences (Nasdaq: ROIV) and Pfizer Inc. (NYSE: PFE) today announced formation of a new Vant to develop and commercialize PF-06480605 (now RVT-3101).
Nov 30, 2022 | miragenews.comPfizer, Inc. invests into assets : Grange Castle manufacturing site in west Dublin in the amount of $1.27B
Life sciences giant Pfizer has revealed plans to invest more than €1.2bn in its Grange Castle manufacturing site in west Dublin.
Nov 30, 2022 | thinkbusiness.iePfizer, Inc. is developing maternal RSV vaccine
Although there is no official vaccine to prevent RSV among children and adults, Pfizer has announced that they are in the process of developing a maternal RSV vaccine that can protect infants from developing severe symptoms during the first six months after birth.
Nov 30, 2022 | americanadoptions.comPfizer, Inc. launches research in the U.S.
The report also reveals that Moderna and Pfizer, the creators of the two mRNA-based jabs, are conducting “the first research in the U.S.” into potential heart problems associated with their products.
Nov 27, 2022 | alor.orgPfizer, Inc. is developing Lyme disease vaccine
Pfizer and the specialty vaccine company Valneva have partnered in developing VLA 15, a potential Lyme disease vaccine.
Nov 25, 2022 | masslive.comPfizer, Inc. is developing mRNA-based flu vaccines in late-stage human studies
Moderna ( MRNA ) and Pfizer ( PFE ) are also developing mRNA-based flu vaccines in late-stage human studies, while GSK ( GSK ) and partner CureVac ( CVAC ) are advancing a similar vaccine in an early-stage trial.
Nov 25, 2022 | seekingalpha.comPfizer, Inc. invests into assets : facility in the amount of $750M
Pfizer announced it will place $750 million into the facility, mainly to establish “modular aseptic processing” (MAP) production and create around 300 jobs at the site.
Nov 23, 2022 | endpts.comPfizer, Inc. is developing Covid-19 vaccines and boosters
As you may be aware, pharmaceutical giant Pfizer (NYSE: PFE ) and BioNTech (NASDAQ: BNTX ) are working together to develop Covid-19 vaccines and boosters.
Nov 23, 2022 | investorplace.comPfizer, Inc. launches Prevnar 13
To combat this child killer, pharmaceutical giant Pfizer released Prevnar 13, a vaccine that covers 13 of the most common strains of PD, a major leap from the old formulation, PCV7, which only covers seven strains.
Nov 23, 2022 | m2comms.comPfizer, Inc. launched clinical trials to track long-term health issues on Nov 23rd 22'.
Also on tap this week: Pfizer and Moderna are launching clinical trials to track long-term health issues following a diagnosis of vaccine-associated myocarditis and pericarditis in teens and young adults, but some experts said the risks are already clear.
Nov 22, 2022 | childrenshealthdefense.orgPfizer, Inc. is developing vaccine for RSV on Oct 22nd 22'.
Pfizer is working on a vaccine for RSV and recently released encouraging results from phase 3 trials.
Nov 22, 2022 | nasdaq.comGlenmark group partnered with Pfizer, Inc. on Nov 22nd 22'.
It works by blocking the action of the abnormal protein that signals cancer... Mumbai: Glenmark Pharmaceuticals Inc., USA (Glenmark) and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer Inc., PF Prism C.V., and PF Prism IMB B.V. for Axitinib Tablets, 1 mg and 5 mg, the generic version of their Inlyta Tablets, 1 mg and 5 mg.
Nov 22, 2022 | medicaldialogues.inOldmutualkenya partners with Pfizer, Inc.
Old Mutual Kenya has partnered with Pfizer and Goodlife Pharmacy to offer Pneumococcal vaccination to its insured members.
Nov 20, 2022 | femmehub.comPfizer, Inc. launched Establishing Antimicrobial Stewardship Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities on Nov 21st 22'.
Earlier this year BSAC and Pfizer launched a collaborative project ‘Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities’.
Nov 20, 2022 | bsac.org.ukPfizer, Inc. launched ‘Vant’ on Nov 24th 22'.
Pfizer and Roivant are teaming up to launch a new ‘Vant’ aimed at bringing a mid-stage anti-inflammatory drug to market, the pair announced Thursday.
Nov 19, 2022 | endpts.comPfizer, Inc. invested into assets : plant in the amount of $1.26B in Dublin, Ireland on Nov 24th 22'.
Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, it said on Thursday, handing the Irish multinational sector a jobs boost at a time when major tech firms are laying off staff.
Nov 18, 2022 | reuters.comPfizer, Inc. expanded facilities to Dublin, Ireland on Nov 24th 22'.
Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, it said on Thursday, handing the Irish multinational sector a jobs boost at a time when major tech firms are laying off staff.
Nov 18, 2022 | reuters.comLucira Health, Inc. partners with Pfizer, Inc.
Lucira is also partnering with Pfizer Inc. to increase awareness and education about the risks of COVID-19 and the availability of treatment options.
Nov 17, 2022 | streetinsider.comPfizer, Inc. recognized as Top 25 ''Dividend Giant
Pfizer has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $34.47B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.29% yield Click here to read full news.
Nov 17, 2022 | latestnigeriannews.comOwen at Pfizer, Inc. receives award 2022 ACS Heroes of Chemistry Award
Dr. Owen and the Pfizer team received the 2022 ACS Heroes of Chemistry Award for the discovery and development of the drug PAXLOVID, used in the acute treatment of COVID-19 patients.
Nov 16, 2022 | drew.eduPfizer, Inc. is developing children’s vaccine
She’s one of the doctors helping Pfizer to develop a children’s vaccine that would protect against the tick-borne disease.
Nov 15, 2022 | wpxi.comPfizer, Inc. is developing RSVpreF for adults
There is no vaccine against RSV, although Pfizer Inc. is developing RSVpreF for adults.
Oct 28, 2022 | theepochtimes.comAcuitastx partnered with Pfizer, Inc. on Jan 1st 22'.
Acuitas Therapeutics recently entered into an agreement with Pfizer to license their LNP technology.
Oct 24, 2022 | techcouver.comPfizer, Inc. is developing Covid-19 vaccine on Oct 18th 22'.
The company developed the first widely approved Covid-19 vaccine with US partner Pfizer.
Oct 20, 2022 | londonglossy.comPfizer, Inc. increased headcount by 75 on Dec 1st 21'.
Up to $40m will be invested and 75 jobs will be created as Pfizer’s Grange Castle site joins global supply chain.
Oct 19, 2022 | thinkbusiness.ieAlthough Bourla leaves Pfizer, Inc. as president
THE FACTS: Social media users are sharing baseless claims suggesting that Bourla resigned from Pfizer and acknowledged that mRNA technology is unsafe.
Oct 19, 2022 | apnews.comPfizer, Inc. partnered with Anokion SA on Oct 18th 22'.
Pfizer will work with Anokion to support the clinical development of KAN-101, according to an Oct. 18 Anokion news release.
Oct 18, 2022 | beckershospitalreview.comPfizer, Inc. invests into Anokion SA in $35M
Pfizer, through its Breakthrough Growth Initiative, has made a $35 million equity investment in Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance.
Oct 17, 2022 | contractpharma.comPfizer, Inc. receives award Best Omni Channel Company of the Year –Multinational Company
Representatives from Pfizer receive the award for Best Omni Channel Company of the Year –Multinational Company.
Oct 14, 2022 | inquirer.netWeber Shandwick partners with Pfizer, Inc.
Weber Shandwick has worked with Pfizer since at least 2006, and partnered with Moderna in June 2022 after the success of the company’s international rollout of COVID-19 vaccines.
Oct 14, 2022 | theepochtimes.comPfizer, Inc. receives award Corporate Leadership Award
Pfizer Inc. (NYSE: PFE) received the Corporate Leadership Award.
Oct 11, 2022 | lymphoma.orgPfizer, Inc. is developing tools, resources, and easy-to-understand materials for patients.
“Pfizer could not realize its purpose without the pivotal role played by patients, caregivers, and advocates — whether engaging in its Research & Development efforts, offering consult on its clinical trial design, or partnering with Unicorn Group to develop tools, resources, and easy-to-understand materials for its patients. ”
Oct 7, 2022 | edo.newsPfizer, Inc. partners with Marvel Comics
Pfizer and BioNTech are collaborating with Marvel to celebrate “everyday” people getting Covid-19 vaccines in a custom comic book.
Oct 5, 2022 | endpts.comPfizer, Inc. launches 2009 PRO guidance
Pfizer explained that the concepts and terms brought up in the guidance “have been introduced with minimal context” and would benefit from explanation in relation to the existing 2009 PRO guidance.
Oct 3, 2022 | raps.orgPfizer, Inc. launches HIV-specific drug company ViiV Healthcare
Pharmaceutical companies GlaxoSmithKline and Pfizer announce the launch of HIV-specific drug company ViiV Healthcare.
Sep 29, 2022 | poz.comModerna, Inc. files suit against Pfizer, Inc.
Moderna, Inc. is filing patent infringement lawsuits against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany.
Sep 28, 2022 | pharmajournalist.comPfizer, Inc. has issues with illegal practices in its marketing
The drug was acquired in the 1990s by Pfizer, which was accused of using illegal practices in its marketing.
Sep 28, 2022 | cirquelodge.comPfizer, Inc. acquires University of Queensland for $179M
Image: supplied Global biopharmaceutical company Pfizer has acquired University of Queensland startup ResApp Health Limited for $179 million.
Sep 26, 2022 | uq.edu.auPfizer, Inc. launches IUdo
Pfizer has launched an innovative digital platform, IUdo for the eligible patients in Qatar.
Sep 25, 2022 | channelpostmea.comPfizer, Inc. has issues with legal battle over patents on mRNA technology
He also addresses the question of access to this vital technology that is used to make COVID-19 vaccines and other medical products Pharma giants Moderna and Pfizer are locked in a legal battle over patents on mRNA technology.
Sep 23, 2022 | peoplesdispatch.orgPfizer, Inc. increases headcount by 500
PepsiCo and Pfizer will each hire 500 refugees.
Sep 20, 2022 | protocol.comPfizer, Inc. is developing MenABCWY
Pfizer is developing a unique pentavalent vaccine, MenABCWY, which addresses all five of the meningitis variants that cause the majority of meningococcal disease.
Sep 15, 2022 | thepharmaletter.comPfizer, Inc. is developing COVID-19 vaccine
Moderna is suing Pfizer and BioNTech, accusing the companies of infringing on Moderna’s patents when they developed their own COVID-19 vaccine.
Sep 14, 2022 | spectrumnews1.comEidogen, Inc. partners with Pfizer, Inc.
San Diego, CA (September 20, 2006) - Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced a worldwide technology licensing agreement with Pfizer Inc, encompassing Eidogen-Sertanty's drug discovery software and database technology.
Sep 13, 2022 | eidogen.comPfizer, Inc. signs new client Paxlovid
Pfizer Inc., New York, New York, was awarded a $4,852,867,500 modification (P00004) to contract W58P05-22-C-0001 for the oral therapeutic PAXLOVID.
Sep 7, 2022 | defense.govAndy Schmeltz leaves Pfizer, Inc. as global president of oncology
Andy Schmeltz will leave his role as global president of oncology at Pfizer to take on a new role of managing the pharma juggernaut’s investment strategies.
Sep 2, 2022 | healtheconomics.comPfizer, Inc. acquired Sicklecell for $5.4B on Aug 2nd 22'.
Pfizer has made a mega purchase recently acquiring Sickle Cell drug maker Global Blood Therapeutics, Inc. for $5.4B.
Sep 1, 2022 | torontocaribbean.comPfizer, Inc. invested into assets : gene therapy manufacturing facility in the amount of $1B in Sanford, Florida, United States on Aug 1st 19'.
In August 2019, Pfizer invested half a billion dollars in Sanford to build a state-of-the-art gene therapy manufacturing facility.
Sep 1, 2022 | bizjournals.comPfizer, Inc. launched "Breakthrough Fellowship Program," on Aug 1st 22'.
Pfizer recently launched a "Breakthrough Fellowship Program," which includes a scholarship for a graduate degree and guaranteed employment, for students and "early career colleagues of Black/African American, Latino/Hispanic and Native American descent," a requirement that could run afoul of federal law.
Aug 31, 2022 | foxbusiness.comPfizer, Inc. hires Andreas "Drew" Panayiotou as chief marketing officer
Andreas "Drew" Panayiotou, currently the chief marketing officer at Google's ( NASDAQ: GOOG ) Verily life sciences unit, is leaving that company to join Pfizer ( NYSE: PFE ) in a similar role.
Aug 31, 2022 | seekingalpha.comPfizer, Inc. is developing mammalian cell culture system
The latest projects include the University of Massachusetts working alongside Whirlcell, Yokogawa Corporation of America, and Pfizer to develop and validate a mammalian cell culture system with an integrated continuous upstream processing platform.
Aug 31, 2022 | biopharma-reporter.comPfizer, Inc. launches RSVpreF
There are a few companies working on RSV vaccine candidates, and Pfizer in particular has announced results from their phase 3 clinical trials of their version called RSVpreF.
Aug 28, 2022 | nphic.orgPfizer, Inc. launches Covid boosters
com) Pfizer, BioNTech and Moderna are working feverishly to launch new Covid boosters ahead of a fall campaign.
Aug 26, 2022 | investors.comfiles suit against Pfizer, Inc.
Moderna, a biotechnology company pioneering messenger RNA therapeutics and vaccines has filed a patent infringement lawsuit against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court of Dsseldorf in Germany.
Aug 26, 2022 | latestnigeriannews.comPfizer, Inc. has issues with patent theft
Moderna files lawsuit against Pfizer over patent theft in first Covid vaccine technology Click here to read full news.
Aug 26, 2022 | latestnigeriannews.comModerna Therapeutics Inc. files suit against Pfizer, Inc.
Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.
Aug 25, 2022 | sky.comPfizer, Inc. is developing Comirnaty vaccine
Moderna accused Pfizer and BioNTech of violating intellectual property rights on key elements of its messenger RNA technology in developing the Comirnaty vaccine.
Aug 25, 2022 | bloomberglaw.comModerna filed suit against Pfizer, Inc. on Aug 26th 22'.
Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US.
Aug 25, 2022 | seasideradio.co.ukPfizer, Inc. has issues with infringing its patent rights in the production of a coronavirus vaccine
The American company Moderna announced that it is filing lawsuits against Pfizer and BioNTech, accusing them of infringing its patent rights in the production of a coronavirus vaccine.
Aug 25, 2022 | gadgettendency.comPfizer, Inc. will have issues with patent infringement on Sep 2nd 22'.
Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine.
Aug 25, 2022 | radiojamaicanewsonline.comPfizer, Inc. launched topline results of PF-06928316’s Renoir study on Aug 25th 22'.
Pfizer today unveiled topline results of PF-06928316’s Renoir study that appeared to miss analysts’ baseline expectations of 70% efficacy.
Aug 25, 2022 | evaluate.comPfizer, Inc. is developing bivalent vaccine
German vaccine developer BioNTech and its U.S. partner Pfizer are also developing a bivalent vaccine for this age group which is adapted to the current Omicron BA.4/BA.5 subvariants, Sahin added.
Aug 24, 2022 | ecns.cnPfizer, Inc. sells assets to Usgovsolutions
The US government has purchased 105 million bivalent Covid-19 vaccine booster doses from Pfizer, and another 66 million updated shots from Moderna.
Aug 23, 2022 | cnn.comPfizer, Inc. is developing COVID-19 drug Paxlovid
Pfizer has partnered with Zhejiang Huahai to produce COVID-19 drug Paxlovid.
Aug 23, 2022 | fiercepharma.comPfizer, Inc. recognized as UK Top Employer
This is the seventh year in a row that Pfizer has been recognised as a UK Top Employer.
Aug 22, 2022 | thehrdirector.comPfizer, Inc. partners with Morgan State University
The collaboration with Morgan State University is part of Pfizer’s continued partnership with Historically Black Colleges and Universities (HBCUs).
Aug 21, 2022 | pharmexec.comPfizer, Inc. sells assets to Usgovernmentquiz
The US government has purchased 105 million bivalent Covid-19 vaccine booster doses from Pfizer, and another 66 million updated shots from Moderna.
Aug 21, 2022 | komu.comPfizer, Inc. is developing updated vaccines to specifically target new versions of Omicron
Pfizer and Moderna are currently developing updated vaccines to specifically target new versions of Omicron that are predicted to be available in Fall 2022.
Aug 14, 2022 | talktomira.comPfizer, Inc. is developing SPR206 in ex- U.S. and ex- Asia territories
Pursuant to the licensing agreement between the parties, Pfizer has the right to develop, manufacture, and commercialize SPR206 in ex- U.S. and ex- Asia territories.
Aug 8, 2022 | sperotherapeutics.comPfizer, Inc. sells assets to Mylan Pharmaceuticals in the amount of $22.6M
However, Pfizer in Q1FY23 did sell its Upjohn business — which has six brands — to Mylan Pharmaceuticals for Rs 180 crore.
Aug 2, 2022 | indiatimes.comPfizer, Inc. expands facilities to Pearl River, New York, United States
Pfizer continues to own 33 acres and occupies about 850,000 square feet of building space on its Pearl River campus.
Jul 24, 2022 | hvicampus.comModerna files suit against Pfizer, Inc.
Moderna has filed a patent infringement lawsuit against Pfizer and BioNTech (Pfizer’s German partner) over mRNA technology Moderna claims to have developed prior to the COVID-19 pandemic, as it seems that the cooperation shown during the COVID-19 pandemic that led to such rapid vaccine development is starting to wear off.
Jul 12, 2022 | slingsbypartners.comPfizer, Inc. has issues with allegedly infringing on its intellectual property rights over mRNA technology used in BioNTech
CureVac has filed a lawsuit against BioNTech, as well as two of its subsidiaries, for allegedly infringing on its intellectual property rights over mRNA technology used in BioNTech and Pfizer’s COVID-19 vaccine.
Jul 6, 2022 | pharmafile.comPfizer, Inc. launched vaccine supply agreement on Jun 29th 22'.
1 On June 29, 2022, Pfizer announced a new vaccine supply agreement with the U.S. government.
Jun 29, 2022 | americaoutloud.comPfizer, Inc. acquired Valneva SE on Jun 1st 22'.
On June 20, Pfizer announced that it would acquire an 8.1% stake in French vaccine company Valneva at a price of 9.49 euros per share, for a total consideration of 90.5 million euros (about 95.24 million U.S. dollars).
Jun 20, 2022 | lunanpharma.comPfizer, Inc. launches Phase 3 study of VLA15
As previously announced on April 26, 2022, Pfizer plans to initiate the Phase 3 study of VLA15 in the third quarter of 2022, they added.
Jun 19, 2022 | reuters.comPfizer, Inc. will launch interim analysis of EPIC-SR on Dec 1st 22'.
Back in December, Pfizer unveiled an interim analysis of EPIC-SR, showing a 70% relative risk reduction in hospitalization or death for Paxlovid over placebo in standard-risk patients.
Jun 15, 2022 | fiercepharma.comPfizer, Inc. is developing omicron-targeted variations of vaccines on Jun 10th 22'.
Vaccine producers Pfizer, Moderna, and Novavax have already been testing omicron-targeted variations of their vaccines, which early information exhibiting that they can assist set off a stronger immune response to the omicron variant than present pictures.
Jun 8, 2022 | iconicverge.comPfizer, Inc. launches initiative to distribute medicines and vaccines to the 1.2 billion people living
For the first time in the industry, Pfizer launched an initiative to distribute its medicines and vaccines to the 1.2 billion people living in 45 lower-income countries at not-for-profit prices.
May 26, 2022 | seekingalpha.comPfizer, Inc. invested into assets : plant in the amount of $1.26B in Dublin, Ireland on Feb 24th 22'.
Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, it said on Thursday, handing the Irish multinational sector a jobs boost at a time when major tech firms are laying off staff.
Feb 17, 2022 | reuters.comPfizer, Inc. launched FDA application for vaccines in the five on Aug 23rd 21'.
But on Feb. 11, Pfizer announced that it would postpone its FDA application for vaccines in the five and under age group, saying it was still waiting for data on a third dose.
Feb 7, 2022 | tsl.newsPfizer Inc. will launch update from a clinical trial showing on Dec 1st 22'.
In December, Pfizer released an update from a clinical trial showing that two doses of the vaccine worked well for children between 6 months and 2 years old but were not as effective in provoking an immune response in 2- to 4-year-olds.
Jan 1, 2022 | upmc.comPfizer Inc. closes offices in Kent, Washington, United States
Drug maker Pfizer is to close its research and development (R&D) facility in Kent, which employs 2,400 people.
Jan 1, 2022 | bbc.comPfizer Inc. receives award 2021 SAMA Excellence Award™ for “Innovative Value Co-Creation
Pfizer is the winner of the 2021 SAMA Excellence Award™ for “Innovative Value Co-Creation.”
Jan 1, 2022 | strategicaccounts.orgPfizer, Inc. is developing Omicron specific boosters
Pfizer and Moderna are working on Omicron specific boosters.
Jan 1, 2022 | ohiohealth.comPfizer, Inc. launches Exubera
When Pfizer launched Exubera in 2006, within five quarters the product was generating $59.8 million in revenue - in the 1st quarter of 2007.
Jan 1, 2022 | seekingalpha.comPfizer, Inc. sells assets to Heritage Global Inc.
Heritage Global Partners is selling laboratory and biopharma R&D assets from Pfizer.
Jan 1, 2022 | industrialauctionnews.comSuzanne Ellery retires from Pfizer, Inc.
She succeeds Suzanne Ellery, who will retire after 34 years with Pfizer.
Jan 1, 2022 | theday.comErmer & Suter PLLC partners with Pfizer, Inc.
Ermer & Suter PLLC collaborated with Pfizer to accelerate development of the pill.
Jan 1, 2022 | ermersuter.comPfizer, Inc. is developing COVID-19 antiviral treatment for children on Mar 9th 22'.
(CNN) - Pfizer is now testing a COVID-19 antiviral treatment for children.
Jan 1, 2022 | kmov.comPfizer, Inc. launches Project Aastha helpdesk
New Delhi: Pfizer launched the Project Aastha helpdesk at the Regional Cancer Center (RCC), Pandit Jawaharlal Nehru Memorial Medical College, Raipur.
Jan 1, 2022 | indiatimes.comPfizer, Inc. received award Breakthrough Therapy Designation on Mar 2nd 22'.
Pfizer announced on March 2, 2022 that it has received Breakthrough Therapy Designation from FDA for its respiratory syncytial virus (RSV) vaccine candidate (RSVpreF).
Jan 1, 2022 | biopharminternational.comPfizer, Inc. expands facilities to Texas, United States
In other sectors, Pfizer announced a 415 MW VPPA from a solar plant in Texas, while Hershey signed agreements for a combined 91 MW from two solar plants.
Jan 1, 2022 | edisonenergy.comPfizer, Inc. launches 2025 Opportunity Parity initiative
Pfizer previously launched the 2025 Opportunity Parity initiative to increase female and minority representation at senior-level positions.
Jan 1, 2022 | wallstreetpr.comPfizer, Inc. has issues with recall of its Accuretic high blood pressure medication due to cancer risk
According to express.co.uk, Pfizer has initiated a recall of its Accuretic high blood pressure medication due to cancer risk.
Jan 1, 2022 | yourlawyer.comPfizer, Inc. is developing vaccine that prevents infection
He said Pfizer is working on developing a vaccine that prevents infection in addition to preventing hospitalizations and severe cases of the virus, adding that making long-lasting vaccines is also a priority.
Jan 1, 2022 | cnbc.comPfizer, Inc. is developing Covid-19 vaccine on Mar 2nd 22'.
Pfizer developed its first Covid-19 vaccine and now over 75% of New Yorkers are fully vaccinated against the virus.
Jan 1, 2022 | mytwintiers.comPfizer, Inc. is developing COVID shot
Pfizer is working on a COVID shot that would work against all variants, including omicron, and maintain its effectiveness for a year, turning the booster into a yearly event like the flu shot.
Jan 1, 2022 | nydailynews.comPfizer, Inc. launches Phase II/III trial of Paxlovid in non-hospitalized symptomatic pediatric patients at risk for progression to severe COVID-19
Pfizer launched a Phase II/III trial of Paxlovid in non-hospitalized symptomatic pediatric patients at risk for progression to severe COVID-19.
Jan 1, 2022 | biospace.comRobert Hollingsworth leaves Pfizer, Inc. as executive
Robert Hollingsworth, Ph.D., a former Pfizer executive who oversaw the development of cancer vaccines and immunotherapeutics, has taken on the role of the chief scientific officer at Shoreline Biosciences.
Jan 1, 2022 | biospace.comPfizer, Inc. has issues with patents for their Covid-19 vaccines
Alnylam Pharmaceuticals Inc. said it had filed lawsuits against Pfizer Inc. and Moderna Inc., alleging that the companies had infringed its patents for their Covid-19 vaccines.
Jan 1, 2022 | bloomberglaw.comPfizer, Inc. launched COVID-19 Vaccine Post Marketing Experience papers on Mar 1st 22'.
As of March 2022, Pfizer has finally released their COVID-19 Vaccine Post Marketing Experience papers.
Jan 1, 2022 | unionofthepeople.comAlnylam Pharmaceuticals, Inc. filed suit against Pfizer, Inc. on Mar 17th 22'.
Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar mRNA COVID-19 vaccines infringe one its patents.
Jan 1, 2022 | devdiscourse.comAlnylam Pharmaceuticals, Inc. files suit against Pfizer, Inc.
Alnylam Pharmaceuticals filed 2 lawsuits in Delaware federal court against Pfizer and Moderna, alleging the companies infringed on patents surrounding the manufacture and sale of their respective messenger RNA vaccines.
Jan 1, 2022 | ajmc.comPfizer, Inc. has issues with recall six lots of Accuretic tablets
Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets.
Jan 1, 2022 | pfizer.comPfizer, Inc. has issues with pharmaceutical giant of stealing trade secrets
Two former Pfizer employees accused by the pharmaceutical giant of stealing trade secrets have filed a cross-claim in which they seek a declaration that they own the patent rights to a first-in-class oral medication to treat obesity and Type 2 diabetes.
Jan 1, 2022 | law.comPfizer, Inc. has issues with alleged infringements of its patent on biodegradable cationic lipids
Alnylam Pharmaceuticals Inc. has filed suits against both Pfizer Inc. and Moderna Inc. over alleged infringements of its patent on biodegradable cationic lipids that it said "are foundational to the success of the mRNA COVID-19 vaccines."
Jan 1, 2022 | bioworld.comPfizer, Inc. partnered with Unicef on Mar 22nd 22'.
Pfizer Inc. (NYSE: PFE) announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), to 95 low- and middle-income countries, pending authorization or approval.
Jan 1, 2022 | businesswire.comPfizer, Inc. has issues with recalling certain batches of its hypertension drug Accuretic
Pfizer - The company announced on Monday evening that it was recalling certain batches of its hypertension drug Accuretic, as well as two generics of the treatment, due to the presence of high levels of nitrosamine, a potentially carcinogenic impurity.
Jan 1, 2022 | marketscreener.comQiu leaves Pfizer, Inc.
Zhong and Qiu resigned from Pfizer 45 months ago and had not heard from their former employer until the lawsuit dropped last month, according to the countersuit.
Jan 1, 2022 | fiercebiotech.comDren partnered with Pfizer, Inc. on Jan 17th 22'.
Dren has announced today collaboration with Pfizer for its Targeted Myeloid Engager and Phagocytosis Platform.
Jan 1, 2022 | mbcbiolabs.comPfizer, Inc. has issues with recall for three high blood pressure medications
Pfizer has issued a recall for three high blood pressure medications, according to the company.
Jan 1, 2022 | wjcl.comPfizer, Inc. launched RSVpreF received Breakthrough Therapy Designation on Mar 24th 22'.
Earlier this month, Pfizer announced RSVpreF received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for the prevention of RSV-associated lower respiratory tract disease in infants from birth up to six months of age by active immunization of pregnant women.
Jan 1, 2022 | businesswire.comPfizer, Inc. closed offices in Netherlands on Jan 1st 07'.
When Pfizer shut down their Holland manufacturing plant, they donated the portion that was a pilot plant to MSU in 2007.
Jan 1, 2022 | hollandrotary.orgTagata Pasifika partners with Pfizer, Inc.
“Tagata Pasifika is working with Pfizer to complete the final requirements detailed in the advance purchase agreement so that shipment can be made at the earliest opportunity.”
Jan 1, 2022 | tpplus.co.nzPfizer, Inc. has issues with alleged trade secret theft
(skegbydave/iStock/Getty Images Plus) The co-founders of a Chinese biotech have countersued their former employer Pfizer in a legal battle over alleged trade secret theft.
Jan 1, 2022 | fiercepharma.comPfizer, Inc. launched mRNA vaccine to the childhood vaccine schedule on Jan 1st 86'.
If Pfizer can add the mRNA vaccine to the childhood vaccine schedule, it will enjoy permanent liability protection under the 1986 National Childhood Vaccine Injury Act.
Jan 1, 2022 | infowars.comPfizer, Inc. is developing Covid-19 vaccine for distribution in Africa
Pfizer is set to invest an extra R255-million in SA to produce the Covid-19 vaccine for distribution in Africa.
Jan 1, 2022 | dailymaverick.co.zaPfizer, Inc. hires Tom Butina as director of patient solutions and alliances marketing
… International pharmaceutical company Pfizer announced the hire of Roseville resident Tom Butina as a director of patient solutions and alliances marketing, leading the company’s This Is Living With Platform.
Jan 1, 2022 | twincities.comPfizer, Inc. launches Pfizer Learning Academy
Globally, Pfizer has launched the Pfizer Learning Academy, an interactive learning platform that curates content from external and internal resources and provides a one-stop solution for the learning needs of employees, who can learn at their own pace.
Jan 1, 2022 | businesstoday.inPfizer, Inc. expands offices to Connecticut, United States
In context, the Kelo case occurred during the time Pfizer Inc. moved to New London, Connecticut.
Jan 1, 2022 | chadbrownlaw.comPfizer, Inc. partnered with Carterra, Inc. on Jan 1st 14'.
In 2014, Pfizer partnered with Carterra with a million-dollar investment.
Jan 1, 2022 | utahbusiness.comPfizer, Inc. is developing versions of mRNA-based shots
With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both Pfizer and Moderna have announced plans to develop new versions of their mRNA-based shots that are tailored to the new variant.
Jan 1, 2022 | pharmaphorum.comPfizer, Inc. launches Alopecia Drug
Pfizer is announcing a new "Alopecia Drug"…guess who their new spokeswoman may be?
Jan 1, 2022 | hitc.comPfizer, Inc. has issues with recalling certain batches of its hypertension drug Accuretic
Pfizer - The company announced on Monday evening that it was recalling certain batches of its hypertension drug Accuretic, as well as two generics of the treatment, due to the presence of high levels of nitrosamine, a potentially carcinogenic impurity.
Jan 1, 2022 | marketscreener.comPfizer, Inc. has issues with ransomware attack
A ransomware attack on a vendor that helps track work time for a multitude of Pfizer’s hourly staffers is causing the pharma giant a major headache.
Jan 1, 2022 | endpts.comPfizer, Inc. is developing vaccine adapted to the spike protein specific to the Omicron variant on Mar 31st 22'.
The German mRNA specialist that partnered with U.S. drugmaker Pfizer is now in the process of testing a vaccine adapted to the spike protein specific to the Omicron variant, which could replace the bulk of its vaccine shipments going forward depending on government demand.
Jan 1, 2022 | fortune.comPfizer, Inc. is developing Omicron-based vaccine on Jan 1st 22'.
By mid-March, BioNTech and its partner Pfizer have signed supply agreements for around 2.4 billion doses of their vaccine for this year, and the two companies were developing an Omicron-based vaccine.
Jan 1, 2022 | germanynews.netPfizer, Inc. expands facilities to Richmond, Victoria, Australia
Pfizer has announced plans to construct a new alternative meat plant in the Richmond LGA, Victoria, right next to a long established abortion clinic.
Jan 1, 2022 | xyz.net.auPfizer, Inc. launches Wuhan coronavirus vaccine
A deep analysis of Pfizer’s trial data has revealed that the company’s Wuhan coronavirus (Covid-19) “vaccine” is likely to “increase illness rather than reduce it.”
Jan 1, 2022 | vaccinedamage.newsPfizer, Inc. recognized as top innovator in the pharmaceutical sector
Pfizer Inc was the top innovator in the pharmaceutical sector in the latest quarter but overall innovation has stalled in the sector.
Jan 1, 2022 | pharmaceutical-technology.comPfizer, Inc. increases headcount by 600
Pfizer hired about 600 additional full-time employees to process adverse event reports during the three months following the Emergency Use Authorization (EUA) of its COVID-19 vaccine, newly released documents reveal.
Jan 1, 2022 | techarp.comGreg Duczynski left Pfizer, Inc. as Senior Vice President for Clinical Operations on Apr 7th 22'.
Enochian BioSciences, Inc., (NASDAQ: ENOB), a company focused on gene-modified cellular and immunotherapies in infectious diseases and cancer, announced today that Greg Duczynski is joining as Senior Vice President for Clinical Operations after a distinguished 32-year career with Pfizer.
Jan 1, 2022 | biospace.comPfizer, Inc. acquired ReViral Ltd. for $525M on Apr 14th 22'.
Pfizer Inc said on Thursday it would buy privately-held ReViral Ltd in a deal worth as much as $525 million, including milestone payments, to gain access to experimental drugs against the respiratory syncytial virus.
Jan 1, 2022 | wincountry.comNational Newspaper Publishers Association partners with Pfizer, Inc.
The National Newspaper Publishers Association (NNPA), in a joint effort with Pfizer and the Voices of the Heart program, held a virtual informational event to raise awareness of hereditary heart failure.
Jan 1, 2022 | tntribune.comPfizer, Inc. acquired ReViral for $525M on Apr 7th 22'.
Investors appeared to view the acquisition of ReViral as a great fit for Pfizer.
Jan 1, 2022 | yahoo.comPfizer, Inc. acquired Monsanto Company on Jan 1st 97'.
Another reason that you might not be surprised about this report is that Pfizer purchased Monsanto and spun it off as subsidiary called Pharmacia in 1997.
Jan 1, 2022 | quicklion.euPfizer, Inc. hired Ramcess Jean-Louis as global chief diversity, equity and inclusion officer on Jan 1st 21'.
In 2021, Pfizer named Ramcess Jean-Louis as its new global chief diversity, equity and inclusion officer, a role in which he’s been charged with further developing the company’s colleague resource groups.
Jan 1, 2022 | prweek.comPfizer, Inc. increased headcount by 1800 on Apr 6th 22'.
Pfizer hired 1,800 additional full-time employees in the first half of 2021 to deal with “the large increase” of adverse reactions to its COVID vaccine, newly released secret documents reveal.
Jan 1, 2022 | amgreatness.comPfizer, Inc. launches Phase 3 study of selective sphingosine 1-phosphate receptor modulator, etrasimod
April 04, 2022 - Pfizer recently announced positive top-line results from a second Phase 3 study of its selective sphingosine 1-phosphate (S1P) receptor modulator, etrasimod, to treat moderately to severely active ulcerative colitis (UC).
Jan 1, 2022 | pharmanewsintel.comPfizer, Inc. partners with Medicaid Cancer Foundation
Pfizer, a multinational pharmaceutical company has partnered with Medicaid Cancer Foundation (MCF) and Leah Foundation to offer free breast cancer screening for women living in Abuja, Kebbi, Niger, Kwara, Kogi and Oyo states.
Jan 1, 2022 | bestnaira.comPfizer, Inc. increases headcount by 2400
Thetrumantribune is still told these “vaccines” are safe and effective, even though Pfizer had to hire an additional 2,400 employees to handle the “large numbers of spontaneous adverse event reports.”
Jan 1, 2022 | thetrumantribune.comPfizer, Inc. is developing Comirnaty
Pharma giant Pfizer collaborated with German biotechnology company BioNTech ( BNTX ) to develop a COVID-19 vaccine, Comirnaty, which became the first vaccine to win U.S. Food and Drug Administration’s (FDA) emergency use authorization and later full approval.
Jan 1, 2022 | tipranks.comPfizer, Inc. is developing inhibitors of eIF4E
It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E.
Jan 1, 2022 | investingnews.comPfizer, Inc. is developing mRNA vaccines for cancer
Both Pfizer and Moderna, credited for the success of their Covid shots, had earlier worked on mRNA vaccines for cancer.
Jan 1, 2022 | indianewengland.comPfizer, Inc. will hire David M. Denton as CFO on May 2nd 22'.
Pfizer Names David M. Denton Chief Financial Officer NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that David M. Denton will join the Company as Chief Financial Officer (CFO) and Executive Vice President effective May 2, 2022.
Jan 1, 2022 | pfizer.comResApp Health Limited partners with Pfizer, Inc.
Australian diagnostic device developer ResApp Health has entered into a $74 million purchase deal with Pfizer, which will help the drugmaker expand into digital health products.
Jan 1, 2022 | fdanews.comPfizer, Inc. launched Supplemental New Drug Application for MYFEMBREE update on Apr 12th 22'.
In accordance with the ongoing review of the application, on April 6, 2022, the U.S. Food and Drug Administration provided notice to the companies that the agency identified deficiencies that preclude discussion of labeling andor ... Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE ) announced today an update on the Supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis.
Jan 1, 2022 | investingnews.comPfizer, Inc. acquired ResApp Health Limited for $74M on Apr 14th 22'.
The deal would be for $74 million, and Pfizer would acquire Resapp Health through its Australian subsidiary.
Jan 1, 2022 | mddionline.comPfizer, Inc. is developing Covid-19 vaccine approved on Mar 22nd 22'.
BioNTech, the German biotech company that partnered with Pfizer to develop the first Covid-19 vaccine approved for use in the U.S., reported fiscal fourth-quarter earnings and sales that topped estimates and said it plans to buy back up to $1.5 billion of stock as well as propose to pay a special dividend.
Jan 1, 2022 | barrons.comPfizer, Inc. acquires Resapp for $71.7M
Biopharmaceutical giant Pfizer has offered AU$100 million (US$74.43 million) to acquire Australian company ResApp, which has developed a mobile app to diagnose COVID-19 by the sound of a person’s cough.
Jan 1, 2022 | betakit.comPfizer, Inc. is developing 2-in-1 COVID-19 protection
Moderna and Pfizer are testing 2-in-1 COVID-19 protection that they hope to offer this fall.
Jan 1, 2022 | idahonews.comPfizer, Inc. is developing Covid-19 vaccine
Dia Dipasupil/Getty Images K athrin Jansen, the vaccine researcher who led Pfizer’s collaboration with BioNTech to develop a Covid-19 vaccine, will retire later this year, the company said.
Jan 1, 2022 | statnews.comPfizer, Inc. has issues with breach of its human rights
Yet Pfizer is claiming that issuing a compulsory license to produce the medicine in the Dominican Republic would be a breach of its human rights.
Jan 1, 2022 | salon.comPfizer, Inc. has issues with nationwide recall of lots of Accupril due to N-nitroso-quinapril content
Pfizer has issued a voluntary nationwide recall of lots of Accupril due to N-nitroso-quinapril content.
Jan 1, 2022 | biopharminternational.comPfizer, Inc. launches Q122 results
Yesterday after market close, AbbVie Inc. ( NYSE: ABBV ) - currently the U.S.' third-largest pharmaceutical company by market cap, behind only Johnson & Johnson ( JNJ ) and Pfizer ( PFE ), announced its Q122 results.
Jan 1, 2022 | seekingalpha.comPfizer, Inc. invests into assets : research and development facility in the amount of $1B in Sanford, North Carolina, United States
In August 2019, Pfizer Inc. announced that the company is now planning to invest nearly half a billion dollars for the expansion of its new research and development facility in Sanford, North Carolina.
Jan 1, 2022 | digitaljournal.comPfizer, Inc. is developing next generation of COVID-19 vaccines and treatments
Pfizer is working on the next generation of COVID-19 vaccines and treatments.
Jan 1, 2022 | theday.comPfizer, Inc. launches Phase 1 clinical trials of mRNA influenza vaccines
Pfizer has already launched Phase 1 clinical trials of mRNA influenza vaccines.
Jan 1, 2022 | pfizer.comPfizer, Inc. launches Every Color is Primary’: a platform
To show its continued commitment in dermatology, we partnered with Pfizer to launch ‘Every Color is Primary’: a platform that raises awareness of disease prevalence, presentation, and impact in patients with skin of color, and helps improve equitable diagnosis and treatment of people of all races and ethnicities.”
Jan 1, 2022 | pharmalive.comPfizer, Inc. expanded facilities to Chennai, Tamil Nadu, India on May 4th 22'.
On Wednesday, the Pharma major Pfizer inaugurated its first drug development centre in Asia at IIT Madras Research Park in Chennai to bring the critical research and development capabilities under one roof.
Jan 1, 2022 | opindia.comPfizer, Inc. launches Humira biosimilar
Pfizer expects to make significant strides in the adalimumab market once it launches its Humira biosimilar late next year, but may not be able to enjoy its anticipated interchangeability designation until 2024.
Jan 1, 2022 | informa.comPfizer, Inc. acquires Wyethusa
She previously led vaccine research at vaccines and health care products maker Wyeth, which was acquired by Pfizer over a decade ago.
Jan 1, 2022 | nasdaq.comPfizer, Inc. is developing mRNA vaccine for seasonal influenza
Prior to Covid-19, Pfizer and BioNTech had been working on an mRNA vaccine for seasonal influenza.
Jan 1, 2022 | microfluidics-mpt.comDiana W. Bianchi at Pfizer, Inc. receives award Health Industry Visionary Award
Diana W. Bianchi, MD, with Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health presented the award Pfizer received the Health Industry Visionary Award, accepted by Judy Sewards, Vice President of the Head of Clinical Trial Experience for Pfizer’s Global Product Development organization.
Jan 1, 2022 | swhr.orgPfizer, Inc. acquires Biohaven Pharmaceuticals, Inc for $11.6B
Pfizer has found a use for a chunk of its Covid windfall, agreeing to buy Biohaven and its migraine drug Nurtec for $11.6 billion.
Jan 1, 2022 | endpts.comPfizer, Inc. acquires Biohaven Pharmaceuticals
Pfizer agreed to buy Biohaven Pharmaceuticals in a cash and stock deal, with Pfizer acquiring all outstanding shares not already owned for $148.50 per share.
Jan 1, 2022 | bloomberglaw.comPfizer, Inc. is developing Omicron-based vaccine candidate and a bivalent COVID-19 vaccine candidate
Pfizer and BioNTech are also working on a new Omicron-based vaccine candidate and a bivalent COVID-19 vaccine candidate.
Jan 1, 2022 | yahoo.comMyrtelle Inc. partnered with Pfizer, Inc. on Jan 1st 21'.
Myrtelle has an exclusive worldwide licensing agreement with Pfizer Inc. for its Canavan disease program.
Jan 1, 2022 | thedailytimes.comPfizer, Inc. invests into assets : portfolio of five pre-clinical CGRP assets
Pfizer also will acquire a portfolio of five pre-clinical CGRP assets.
Jan 1, 2022 | ropesgray.comPfizer, Inc. invested into assets : sterile injectable plant in the amount of $465M in Portage, Michigan, United States on Jul 1st 20'.
For example, in July 2020, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan.
Jan 1, 2022 | pharmiweb.comPfizer, Inc. launches different vaccine packaging
Minister of Health, Dr. Frank Anthony (Photo: DPI) And to ensure that the required dosage for children aged five to 11 (10 micrograms) is not mixed up with the dosage administered to adults, the Pfizer Company has introduced a different vaccine packaging- that is, there is a unique label and different cap colour.
Jan 1, 2022 | newsroom.gyPfizer, Inc. launched game Minecraft on Aug 1st 17'.
In August 2017, Pfizer announced the launched their game Minecraft with some modifications which will help the children with hemophilia to learn about safety and will maintain their treatment plans.
Jan 1, 2022 | magnolianews.netPfizer, Inc. acquires Nurtec
And that is why Pfizer has taken precautionary measures by acquiring Nurtec for migraines.
Jan 1, 2022 | industryleadersmagazine.comPfizer, Inc. launches positive midstage pediatric data on VLA15
Partners Valneva and Pfizer have released positive midstage pediatric data on VLA15, their Lyme disease vaccine candidate.
Jan 1, 2022 | smartbrief.comPfizer, Inc. launched Health Equity, Advocacy and Leadership on Apr 10th 22'.
Most recently, Pfizer partnered with the Tigerlily Foundation to launch Health Equity, Advocacy and Leadership (HEAL) sessions to advance education around clinical trials for Black women with cancer.
Jan 1, 2022 | atlantatribune.comPfizer, Inc. launches two pilot projects in the DACH region
Pfizer has launched two pilot projects in the DACH region.
Jan 1, 2022 | highp.mePfizer, Inc. launches set of documents about the SARS-CoV-2 vaccine
Users claimed that Rady Johnson was arrested after Pfizer released a new set of documents about the SARS-CoV-2 vaccine.
Jan 1, 2022 | factcrescendo.comPfizer, Inc. partnered with Sanofi Genzyme on Dec 1st 16'.
In December 2016, Pfizer launched an app in order to support patients with depression.The New York health system announced that it will be partnering with Sanofi and digital health company Sema4 on the remote monitoring program.
Jan 1, 2022 | digitaljournal.comPfizer, Inc. launched Phase III study CIFFREO evaluating fordadistrogene movaparvovec for the treatment of Duchenne muscular dystrophy on Apr 28th 22'.
On April 28 th, Pfizer announced the reactivation of its Phase III study CIFFREO evaluating fordadistrogene movaparvovec (PF-06939926) for the treatment of Duchenne muscular dystrophy (DMD).
Jan 1, 2022 | kaloramainformation.comPfizer, Inc. launched two recalls of drugs on Apr 18th 22'.
In the last month, Pfizer has launched two recalls of popular drugs due to nitrosamine.
Jan 1, 2022 | legalexaminer.comPfizer, Inc. will develop digital patient support programmes globally on Jan 1st 24'.
This marks the next phase of a growing collaboration between Sidekick and Pfizer to develop digital patient support programmes globally, including expansion into 24 markets by 2024.
Jan 1, 2022 | mobihealthnews.comPfizer, Inc. closed offices in Chanute, Kansas, United States on Mar 1st 22'.
The two final-phase studies of etrasimod are the first to read out after Pfizer closed its Arena buyout in March.
Jan 1, 2022 | investors.comPfizer, Inc. launched An Accord for a Healthier World on May 25th 22'.
Pfizer on Wednesday launched “An Accord for a Healthier World”.
Jan 1, 2022 | dhakatribune.comNorthern Light Health partners with Pfizer, Inc.
Mainers will be able to participate in clinical trials for a Lyme disease vaccine later this year, as the Brewer-based Northern Light Health system partners with Pfizer to help it run the next round.
Jan 1, 2022 | bangordailynews.comPfizer, Inc. launches initiative, ‘An Accord
The company aims to provide support for 1.2 billion people in 45 lower-income countries Pfizer has launched a new initiative, ‘An Accord for a Healthier World’, to improve existing global health inequalities.
Jan 1, 2022 | pmlive.comPfizer, Inc. is developing inhibitors of eIF4E
It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E.
Jan 1, 2022 | investorsobserver.comPfizer, Inc. received award Diversity Star Award on May 26th 21'.
Last year’s winners included world-renowned brands such as Pfizer, who won the Diversity Star Award for their use of HireVue in their Breakthrough Fellowship Program.
Jan 1, 2022 | globenewswire.comKathrin U. Jansen retires from Pfizer, Inc. as Senior Vice President and Head of the Company's Vaccine Research & Development
NEW YORK, June 1, 2022 - Pfizer Inc. (NYSE: PFE) today announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine Research & Development (R&D) organization effective August 1, succeeding Kathrin U. Jansen, Ph.D., who will be retiring from Pfizer.
Jan 1, 2022 | marketscreener.comPfizer, Inc. is developing medicines and vaccines
Pfizer said that selling its ownership in Haleon is keeping with its focus on developing innovative new medicines and vaccines.
Jan 1, 2022 | medcitynews.comPfizer, Inc. will hire Annaliesa Anderson as Senior Vice President and Head of the Company's Vaccine Research & Development on Aug 1st 22'.
Annaliesa Anderson, Ph.D., will become Pfizer's head of vaccine R&D on August 1.
Jan 1, 2022 | fiercepharma.comPfizer, Inc. decreased headcount by 300 on Jan 1st 18'.
Pfizer reportedly completely abandoned Alzheimer’s research in 2018 and laid off 300 employees.
Jan 1, 2022 | axiswire.comCansinotech partners with Pfizer, Inc.
This came as CanSino Biologics (6185) has terminated collaboration with Pfizer on the promotion of a meningococcal conjugate vaccine.
Jan 1, 2022 | thestandard.com.hkPfizer, Inc. will increase headcount by 250 on Jun 13th 22'.
Pfizer is to announce Monday it will add 250 new jobs to its Portage manufacturing site to boost production of its antiviral COVID-19 pill Paxlovid.
Jan 1, 2022 | yahoo.comPfizer, Inc. will invest into assets : manufacturing facility in the amount of $120M in Kalamazoo, Michigan, United States on Jun 13th 22'.
The Kalamazoo site is Pfizer’s largest manufacturing facility.
Jan 1, 2022 | fiercepharma.comPfizer, Inc. will invest into assets : 1,300-acre Portage operations in the amount of $250M on Jun 13th 22'.
Pharmaceutical giant Pfizer announced Monday it would invest $250 million into its 1,300-acre Portage operations to produce ingredients for its COVID-19 antiviral pill Paxlovid.
Jan 1, 2022 | crainsdetroit.comPfizer, Inc. expands offices in Kalamazoo, Michigan, United States
Pfizer said the expansion will create more than 250 high-skilled manufacturing jobs in Kalamazoo County.
Jan 1, 2022 | wchstv.comGretchen Whitmer left Pfizer, Inc. as Michigan Governor on Jun 6th 22'.
Michigan Governor Gretchen Whitmer joined representatives from Pfizer, in Kalamazoo County on Monday, June 6, for a tour of the facility.
Jan 1, 2022 | cbslocal.comPfizer, Inc. will expand facilities to Kalamazoo, Michigan, United States on Jun 13th 22'.
Wearing a "Science Will Win" T-shirt beneath her navy blue blazer, Gov. Gretchen Whitmer hailed the announcement Monday that Pfizer is adding 250 more jobs and will invest $120 million in its Kalamazoo County manufacturing facility as "one more step in our battle to beat back COVID-19 and keep people safe and healthy."
Jan 1, 2022 | freep.comPfizer, Inc. invested into assets : facility in the amount of $120M in Kalamazoo, Michigan, United States on Jun 6th 22'.
New York-based Pfizer Inc. announced today that it would further strengthen its commitment to U.S. manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility.
Jan 1, 2022 | precisionvaccinations.comPfizer, Inc. hired Gretchen Whitmer on Jun 6th 22'.
Gov. Gretchen Whitmer joined Pfizer for the announcement on Monday, June 6.
Jan 1, 2022 | wnem.comPfizer, Inc. partners with Medidata Solutions
Pfizer announced partnerships in drug discovery and disease severity scoring, while Thermo Fisher Scientific announced that it was partnering with Medidata Acorn AI to optimize clinical trials.
Jan 1, 2022 | businesswire.comUniversity of Benin Teaching Hospital partnered with Pfizer, Inc. on Jun 9th 22'.
The management of the University of Benin Teaching Hospital, through its Infection Prevention and Control Committee in collaboration with Pfizer today 8/6/022, held a one-day workshop on case management of Monkeypox, Integrated Disease Surveillance, and Response activities as well as Standard precautions.
Jan 1, 2022 | ubth.orgPfizer, Inc. is developing vaccines against Covid-19
The new shot is developed by BioNTech based on the same technology used by the German biotech company along with its US partner Pfizer to develop vaccines against Covid-19.
Jan 1, 2022 | ummid.comPfizer, Inc. acquired Trilliummedicalcenter on Jan 1st 21'.
Pfizer’s acquisition of Trillium was one of the top 10 biopharmaceutical M&A deals announced in 2021, measured by deal value on data published by PharmaCompass.
Jan 1, 2022 | ropesgray.comPfizer, Inc. launches TV commercial for Cibinqo
Pfizer debuted its first TV commercial for Cibinqo, its next-gen oral JAK inhibitor to treat eczema, with a splashy special effects spot about the “new innovation from Pfizer.”
Jan 1, 2022 | endpts.comPfizer, Inc. invested into assets : plant in the amount of $120M in Michigan, United States on Jun 13th 22'.
Pfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.
Jan 1, 2022 | indiatimes.comPfizer, Inc. launches two drugs, Vyndaqel and Vyndamax
Pfizer has introduced two drugs, Vyndaqel and Vyndamax, which are the only Food and Drug Administration (FDA)-approved medications for the condition; the only other treatment option is a very expensive and risky heart and liver transplant procedure.
Jan 1, 2022 | jdsupra.comTruveta Inc partnered with Pfizer, Inc. on Jun 23rd 22'.
Truveta today announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale.
Jan 1, 2022 | clival.comPfizer, Inc. is developing vaccine for Lyme disease
Pfizer has acquired a stake in Valneva, a French biotech company, to jointly develop a vaccine for Lyme disease.
Jan 1, 2022 | econotimes.comPfizer, Inc. had issues with recalling 1 million packages of its Lo/Ovral-28 tablets and generic Norgestrel and Ethinyl Estradiol tablets, because some of the birth control tablets on Feb 1st 12'.
On February 1, 2012, Pfizer announced that it is recalling 1 million packages of its Lo/Ovral-28 tablets and generic Norgestrel and Ethinyl Estradiol tablets, because some of the birth control tablets may be out of sequence, or there may be more of the active pills in some packages and more inactive pills in other packages.
Jan 1, 2022 | sinalawgroup.comPfizer, Inc. partners with One Young World Limited
Pfizer is partnering with One Young World for the second year and will support 50 young leaders to attend the One Young World Summit 2022.
Jan 1, 2022 | africaextended.comPfizer, Inc. partners with Headlands Research
In fact, TrialSite’s O’Connor learned at this event that Pfizer partnered with the national trial site organization Headlands Research to build from the ground up trial site locations in minority communities.
Jan 1, 2022 | totaldiversity.comPfizer, Inc. is developing vaccine that will work against SARS-CoV-2
With the knowledge that any of the other coronaviruses could pose a serious future threat, Pfizer and its partner BioNTech announced plans on Wednesday to develop a vaccine that will work against SARS-CoV-2 (the virus that causes COVID-19) and the entire class, or family, of related coronaviruses.
Jan 1, 2022 | sharylattkisson.comSirana Pharma partners with Pfizer, Inc.
German biotech Sirana Pharma entered a collaborative research agreement with Pfizer to investigate the potential identification and validation of a novel treatment concept for a rare bone disease.
Jan 1, 2022 | globalgenes.orgPfizer, Inc. goes public
Following Haleon’s initial public offering (IPO) and the lock-up period, Pfizer ( PFE ) is then expected to reduce its stake in Haleon.
Jan 1, 2022 | capital.comPfizer, Inc. identified as competitor of AbbVie Inc.
Pfizer currently plans to launch ABRILADA in the U.S. as early as July 2023 in accordance with the terms of its agreement with AbbVie.
Jan 1, 2022 | pfizer.comPfizer, Inc. identified as competitor of AbbVie Inc.
Pfizer currently plans to launch ABRILADA in the U.S. as early as July 2023 in accordance with the terms of its agreement with AbbVie.
Jan 1, 2022 | pfizer.comTouchlight Genetics Ltd partners with Pfizer, Inc.
Touchlight, which has been netting deals in the ever-expanding and competitive DNA manufacturing space, has inked a non-exclusive patent license agreement with Pfizer.
Jan 1, 2022 | endpts.comPfizer, Inc. partnered with Roivant Sciences on Sep 1st 21'.
Priovant was created in September 2021 when Pfizer partnered with Roivant.
Jan 1, 2022 | biospace.comPfizer, Inc. is developing COVID-19 vaccine
The American Society of Transplantation (AST) and United Network of Organ Sharing (UNOS), for example, list vaccine manufacturing giant Sanofi—which partnered with both Pfizer and Johnson & Johnson to produce the COVID-19 vaccine—among their corporate sponsors.
Jan 1, 2022 | loveworlduk.orgPfizer, Inc. hired Hazen Marshall on Dec 1st 21'.
In December 2021, Pfizer hired a well-connected lobbyist, Hazen Marshall, and the law firm Williams & Jensen to lobby against the bill.
Jan 1, 2022 | prepareforchange.netCodexis, Inc. partnered with Pfizer, Inc. on Jul 14th 22'.
Codexis ( NASDAQ: CDXS ) on Thursday said it had inked a deal with Pfizer ( PFE ) to make an enzyme used to manufacture nirmatrelvir, which is an active pharmaceutical ingredient in the U.S. drug giant's COVID-19 antiviral pill Paxlovid.
Jan 1, 2022 | seekingalpha.comPfizer, Inc. files suit against Amgen Foundation, Inc.
Pfizer is suing Amgen in Europe over a patent issue, one in which both companies have long gone back and forth.
Jan 1, 2022 | endpts.comPfizer, Inc. is developing Omicron specific vaccines to fight the newest variants
Both Pfizer and Moderna are currently working on developing Omicron specific vaccines to fight the newest variants.
Jan 1, 2022 | nctv17.comPfizer, Inc. launched outcomes-based warranty programme for Xalkori on Jul 15th 21'.
Last year, Pfizer introduced an outcomes-based warranty programme for Xalkori that offers a refund on the cost of the drug if a patient does not see a benefit from treatment.
Jan 1, 2022 | pharmaphorum.comPfizer, Inc. files suit against Teva Pharmaceuticals USA Inc
Pfizer has sued Teva Pharmaceuticals in Delaware federal court for allegedly rushing to make a generic version of Pfizer's arthritis drug Xeljanz XR before a patent on the treatment expires.
Jan 1, 2022 | law360.comBioPharm International partners with Pfizer, Inc.
“BioPharm International is delighted to establish this agreement with Pfizer to license its mRNA manufacturing platform.
Jan 1, 2022 | biopharminternational.comPfizer, Inc. is developing vaccine towards COVID-19
The corporate, in collaboration with Pfizer Inc., developed a vaccine towards COVID-19.
Jan 1, 2022 | globalonlinemony.comPfizer, Inc. is developing Paxlovid
Pfizer Inc has been developing a COVID-19 antiviral drug, Paxlovid.
Jan 1, 2022 | generationmedics.org.ukPfizer, Inc. is developing vaccines targeting BA.4 and BA.5
Pfizer and Moderna are working to develop new vaccines targeting BA.4 and BA.5, following the FDA’s recommendation of including an Omicron component in COVID-19 booster vaccines for the 2022 fall and winter seasons.
Jan 1, 2022 | medicalnewstoday.comPfizer, Inc. invests into assets : vaccine research facilities 25 miles northwest in the amount of $470M in New York, New York, United States
Pfizer Inc. will spend $470 million to expand its vaccine research facilities 25 miles northwest of New York City, where the company hopes to maintain its edge in the booming field of messenger RNA, the technology behind its blockbuster Covid-19 shot.
Jan 1, 2022 | bloomberg.comPfizer, Inc. invests into assets : building and renovate existing facilities in the amount of $470M
Bloomberg reported that Pfizer will invest $470 million to construct a building and renovate existing facilities located on its campus in Pearl River, which is 25 miles northwest of New York.
Jan 1, 2022 | bioprocessintl.comSandy retires from Pfizer, Inc.
Sandy retired from Pfizer after 27 years and moved to Neosho, Missouri, where she shared 20 years with Raymond.
Jan 1, 2022 | commercial-news.comPfizer, Inc. launches Direct Copay Assistance Program
To help patient’s afford the medications, Pfizer created the Direct Copay Assistance Program.
Jan 1, 2022 | jurist.orgPfizer, Inc. launches NGENLA
Pfizer launched NGENLA ® (somatrogon) in Germany, Japan and additional global markets.
Jan 1, 2022 | opko.comPfizer, Inc. invests into Truth in $40M funding
Truth received $40 million in funding from Pfizer and The Pfizer Foundation, a manufacturer of traditional nicotine replacement products that has seen sales decline from people switching to vaping.
Jan 1, 2022 | vapekit.co.ukPfizer, Inc. invested into Akero Therapeutics, Inc. in $25M on Jun 15th 22'.
On June 15, 2022, Akero secured a $25 million equity investment from Pfizer, Inc. and an up to $100 million term loan facility from Hercules Capital, Inc., of which (i) $10.0 million was drawn at closing, (ii) an incremental $10.0 million is available to Akero at its sole discretion, (iii) $35 million will become available upon the achievement of certain clinical development and financial milestones, and (iv) $45.0 million will become available at Hercules’ sole discretion.
Jan 1, 2022 | tmcnet.comPfizer, Inc. invested into assets : manufacturing facility in the amount of $120M in Kalamazoo, Michigan, United States on Jul 2nd 22'.
Pfizer recently invested $120 million in its manufacturing facility in Kalamazoo, Michigan.
Jan 1, 2022 | thomasnet.comPfizer, Inc. acquired Global Blood Therapeutics, Inc. for $5B on Jun 28th 22'.
The Wall Street Journal reported today that Pfizer is in the final stages of acquiring Global Blood Therapeutics for $5 billion.
Jan 1, 2022 | endpts.comPfizer, Inc. acquired Global Blood Therapeutics, Inc. for $5B on Jun 28th 22'.
The Wall Street Journal reported today that Pfizer is in the final stages of acquiring Global Blood Therapeutics for $5 billion.
Jan 1, 2022 | endpts.comS. Sridhar leaves Pfizer, Inc. as Managing Director
Pharmaceutical company Pfizer Limited announced that S. Sridhar has resigned from the role of Managing Director of the company.
Jan 1, 2022 | hrnxt.comPfizer, Inc. invests into assets : campus in the amount of $60M
From St. Louis Post-Dispatch: Pfizer has started construction on a $60 million expansion of its campus here that will grow its employment and boost the company’s vaccine production.
Jan 1, 2022 | constructforstl.orgPfizer, Inc. launched vaccine against Borrelia burgdorferi, the tick-borne bacteria that cause Lyme disease on Aug 8th 22'.
As The Times previously reported, the pharmaceutical companies Pfizer and Valneva have developed a vaccine against Borrelia burgdorferi, the tick-borne bacteria that cause Lyme disease, and plan to begin phase 3 trials of the vaccine.
Jan 1, 2022 | mvtimes.comPfizer, Inc. is developing human Lyme vaccine
In order to combat the potential spread of Lyme in humans, Pfizer and French drugmaker Valneva are working on a new human Lyme vaccine.
Jan 1, 2022 | criver.comLouisiana Healthcare Connections Inc. partners with Pfizer, Inc.
With the goal of addressing barriers some parents face in scheduling and understanding recommended immunization schedules for infants and children, Louisiana Healthcare Connections has partnered with Pfizer on the Vaccine Adherence in Kids program (VAKs).
Jan 1, 2022 | louisianahealthconnect.comPfizer, Inc. invests into assets : Chesterfield research and development facility in the amount of $236M
Construction is underway on an expansion to Pfizer's $236 million Chesterfield research and development facility.
Jan 1, 2022 | ksdk.comCentene Corp. partners with Pfizer, Inc.
To help parents and caregivers gain an understanding of recommended immunizations and schedules for children, several Centene health plans have partnered with Pfizer to launch the Vaccine Adherence in Kids program, or VAKs.
Jan 1, 2022 | centene.comPfizer, Inc. is developing improved version of Paxlovid
Pfizer is reportedly working on an improved version of Paxlovid that would make it less problematic for people taking other medications, and the Japanese company Shionogi developed a once-a-day drug that works similarly to Paxlovid (which must be taken multiple times a day), that could be approved within months.
Jan 1, 2022 | grid.newsPfizer, Inc. launches Hemocraft application
An early example, Pfizer launched the Hemocraft application that utilizes a modified version of the popular Minecraft gaming system to provide an immersive environment for younger individuals with hemophilia to learn the importance of, and how to manage their treatment routines.
Jan 1, 2022 | indegene.comPfizer, Inc. is developing Omicron-specific vaccine on Dec 5th 20'.
Pharmaceutical giant Pfizer is developing an Omicron-specific vaccine, recently publishing results showing it was safe and better targeted the variant.
Jan 4, 2021 | teammedcentres.com.auPfizer Inc. has issues with recall on one of their drugs called Chantix
Pfizer has issued a recall on one of their drugs called Chantix.
Jan 1, 2021 | plattwellness.comLehigh Valley Health Network partners with Pfizer, Inc.
This is not the first time LVHN has partnered with Pfizer.
Jan 1, 2021 | lvhn.orgPfizer, Inc. partnered with Iktos on Jan 1st 21'.
This is likely an attempt to keep pace with its peers, which are also tapping into AI to speed up R&D: In March, Pfizer teamed up with Iktos to apply the startups’ AI software to Pfizer’s small-molecule drug design programs, for instance.
Jan 1, 2021 | emarketer.comPfizer, Inc. partnered with Unicef Nl on Mar 4th 21'.
NEW YORK - Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX), in partnership with UNICEF, today announced the arrival of the first doses of their COVID-19 vaccine in Rwanda through the COVAX Facility.
Jan 1, 2021 | marketscreener.comPfizer, Inc. partnered with IDA Foundation on Feb 9th 21'.
NEW YORK, February 9, 2021 - Pfizer today announced a partnership with IDA Foundation, an independent social enterprise providing essential medicines to low-and middle-income countries, to provide equitable access to quality cancer treatments in almost 70 developing countries across Latin America, Asia, Africa and the Western Pacific region.
Jan 1, 2021 | pfizer.comPfizer, Inc. partners with Premierpet
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program.
Jan 1, 2021 | informa.comStrata Oncology partners with Pfizer, Inc.
In March, Strata Oncology announced its clinical program with the Strata PATH trial and Pfizer as its first partner and in January, the company announced plans to begin enrolling in its Sentinel Trial.
Jan 1, 2021 | benzinga.comPfizer, Inc. launches NetBasis Cost Basis system
As a helpful service to our shareholders, Pfizer Inc. is making available the NetBasis Cost Basis system via a hyperlink on our Web site.
Jan 1, 2021 | pfizer.comPfizer, Inc. is developing mRNA vaccine to fight the Covid-19 pandemic on Oct 22nd 21'.
Recently, the popularity of this mixing principle drastically increased thanks to the process develop by Pfizer to produce their mRNA vaccine to fight the Covid-19 pandemic.
Jan 1, 2021 | manetco.beErasca, Inc. partnered with Pfizer, Inc. on Sep 8th 21'.
Erasca, Inc. ( ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced a clinical trial collaboration and supply agreement with Pfizer Inc. (: PFE) for the BRAF inhibitor encorafenib (BRAFTOVI ® ).
Jan 1, 2021 | gurufocus.comPfizer, Inc. had issues with allegedly stealing confidential documents related to its COVID-19 vaccine and other drugs on Nov 25th 21'.
It appears Pfizer Inc has reached a truce with a former long-time employee it sued two weeks ago for allegedly stealing confidential documents related to its COVID-19 vaccine and other drugs.
Jan 1, 2021 | blackheritageradio.comChildren’s Cancer Cause partnered with Pfizer, Inc. on Mar 19th 21'.
Children’s Cancer Cause recently collaborated with Pfizer, Inc. on a focus group around how to make better medicines to treat children and young adults.
Jan 1, 2021 | childrenscancercause.orgOmicron Development LLC partnered with Pfizer, Inc. on Nov 29th 21'.
DE), partnering with Pfizer (PFE.N), said on Monday it had started work on a version of its established COVID-19 shot that is tailored to Omicron, though it was not yet clear if it was necessary.
Jan 1, 2021 | reuters.comPfizer, Inc. launches program “Eczema Inside Out”
For instance, Pfizer, Inc. announced a new program “Eczema Inside Out” in collaboration with patient advocacy organizations from various countries.
Jan 1, 2021 | digitaljournal.comJohnabbott at Pfizer, Inc. recognized as one of Canada’s Best Diversity Employers and one of Canada’s Top Employers for Young People for 2022.” on Jan 24th 21'.
Johnabbott hope to be inspiring role models as Pfizer was recently named one of Canada’s Best Diversity Employers and one of Canada’s Top Employers for Young People for 2022.”
Jan 1, 2021 | johnabbott.qc.caPfizer, Inc. launched trials of vaccines for children under 12 on Mar 1st 21'.
In March, both Pfizer and competitor Moderna launched trials of their vaccines for children under 12.
Jan 1, 2021 | timesofisrael.comPfizer, Inc. acquired Vicuron Pharmaceuticals for $1.9B on Sep 1st 05'.
From 2000 to 2005, Dr. Goldstein served as Chief Financial Officer of Vicuron Pharmaceuticals, Inc., raising over $250 million in equity financings, facilitating company partnership transactions and participating in the M&A process when Vicuron was acquired by Pfizer, Inc. for $1.9 billion.
Jan 1, 2021 | streetinsider.comPfizer, Inc. launches Vyndamax
A similar treatment that Pfizer launched in 2019 called Vyndamax succeeded on the same outcome measurement that acoramidis failed to meet.
Jan 1, 2021 | fool.comPfizer, Inc. increases headcount by 100
Mangipudy also said Pfizer is looking to hire for at least 100 new positions in Groton as part of the expansion.
Jan 1, 2021 | theday.comPfizer, Inc. increases headcount by 1800
According to recently leaked secret records, Pfizer hired 1,800 additional full-time employees in the first half of 2021 to deal with “the large increase” in adverse reactions to its COVID vaccination.
Jan 1, 2021 | biotechexpressmag.comIan Smith leaves Pfizer, Inc. as chairman and co-founder
Smith, a former Pfizer executive remembering the press releases around Arbor’s launch, said yes.
Jan 1, 2021 | endpts.comPfizer, Inc. launched Covid-19 treatments in Korea on Feb 1st 21'.
The health authorities said they began a specific discussion with MSD (known as Merck in the U.S.) and Pfizer to introduce oral Covid-19 treatments in Korea in February next year.
Jan 1, 2021 | koreabiomed.comPfizer, Inc. launched low-dose vaccine for kids on May 7th 22'.
Pfizer said its low-dose vaccine for kids (which is a third of the dosage given to adults) is more than 90 percent effective in preventing symptomatic infection.
Jan 1, 2021 | hartfordhealthcare.orgSignum Health Ltd partnered with Pfizer, Inc. on Aug 1st 19'.
Its leading product in development is Somatrogon (hGH-CTP), a once-weekly human growth hormone for which Signum Health Ltd has partnered with Pfizer, Inc. ("Pfizer") and successfully completed a phase 3 study in August 2019.
Jan 1, 2021 | marketscreener.comPfizer, Inc. is developing knock-off of Ivermectin
That’s why Pfizer is developing a knock-off of Ivermectin to sell at 10x the price.
Jan 1, 2021 | azld15gop.orgPfizer, Inc. is developing potential cancer vaccine
And there’s this: When COVID hit, Pfizer researchers were working on a potential cancer vaccine based on the MRNA technique they put to use against COVID.
Dec 13, 2020 | chelseanewsny.comRedbiotec AG sold assets to Pfizer Inc. on Jan 1st 14'.
That amount includes funding for the human cytomegalovirus business that Redbiotec spun off and sold to Pfizer in 2014.
Jan 1, 2020 | mergermarket.comPfizer, Inc. is developing 1.3 billion doses and Moderna 1.0 billion although two doses are needed for each vaccination on Jan 1st 21'.
Production levels for 2021 could be high with drugs company Pfizer expecting to produce 1.3 billion doses and Moderna 1.0 billion although two doses are needed for each vaccination.
Jan 1, 2020 | sharingpensions.co.ukPfizer, Inc. acquired American Bamboo Society on Jan 1st 16'.
In 2016, Pfizer acquired Bamboo, providing it with a leading gene therapy for Duchenne muscular dystrophy.
Jan 1, 2020 | pmlive.comCroda International partnered with Pfizer, Inc. on Oct 18th 20'.
For instance, in November speciality chemical business Croda International signed an agreement with Pfizer to supply novel substances, called excipients, in the manufacture of its vaccine.
Jan 1, 2020 | thebusinessdesk.comPfizer, Inc. receives financing of $455M in German government grant
Pfizer has received a US$455 million German government grant and nearly US$6 billion in US and EU purchase commitments.
Jan 1, 2020 | asiasentinel.comPfizer, Inc. received financing of $1.95B in funding on Jul 21st 20'.
The requests specifically ask for written agreements created with drug companies, including Pfizer and BioNTech, which together received $1.95 billion in funding, GlaxoSmithKline and Sanofi Pasteur, which together received $2.04 billion in funding, and Novavax, which received $1.6 billion in funding.
Jan 1, 2020 | americanoversight.orgFosun International Ltd. partners with Pfizer, Inc.
Fosun has partnered with Pfizer and BioNTech to develop a vaccine that’s in late-stage trials, so here’s hoping.
Jan 1, 2020 | fortune.comPfizer, Inc. acquired Anacor Pharmaceutical for $5.2B on May 1st 16'.
Another argument against Pfizer acquiring Anacor is that it could get more bang for the buck by buying or licensing phase 2 or phase 3 assets.
Jan 20, 2019 | fool.comPfizer Inc. launches Trackit
Two years ago, Pfizer built a now award-winning app - Trackit - to improve the traceability and efficiency of products through the supply chain, and better ensure on-time delivery of medicine to patients.
Jan 1, 2019 | pwc.beDavy Group invests into Pfizer, Inc.
Davy Asset Management Limited invested 2.5% in Pfizer Inc. (NYSE:PFE).
Jan 1, 2019 | ztribune.comPfizer, Inc. invested into Strata Oncology in $26M on Jan 1st 18'.
Strata Oncology received $90 million in funding from Pfizer, Merck, and other pharma companies.
Jan 1, 2019 | cronicle.pressPfizer, Inc. identified as competitor of Sarepta Therapeutics, Inc.
One of the first six people to receive the treatment was hospitalized with acute renal injury, leading analysts to talk down Pfizer’s chances of competing with Sarepta.
Jan 1, 2019 | fiercebiotech.comPfizer, Inc. expands facilities to Austria
With a symbolic ground-breaking ceremony, the pharmaceutical company Pfizer has given the go-ahead for a comprehensive expansion of its production facility in Orth an der Donau (Lower Austria).
Jan 1, 2019 | vindobona.orgPfizer, Inc. closes offices in United Kingdom
Pfizer ($PFE) will close a couple of plants in the U.K., with more than 370 jobs on the line, but the U.S. company wants everyone to know that its exi ...
Dec 31, 2018 | pharmatips.inThe Burney Company invests into Pfizer, Inc.
Burney has invested 0.36% of its capital in Pfizer Inc. (NYSE:PFE).
Jan 1, 2018 | ztribune.comPfizer, Inc. sold assets to Bioventus Inc. on Jan 1st 13'.
Bioventus acquired the exclusive, worldwide license to the BMP portfolio of development programs and associated intellectual property from Pfizer, Inc., in 2013.
Jan 1, 2018 | orthospinenews.comPfizer, Inc. received financing of $11B on Feb 16th 18'.
Pfizer received almost $11 billion in tax benefits and last year they instituted 116 price hikes.
Jan 1, 2018 | burnettcountysentinel.comGlaxoSmithKline identified as competitor of Pfizer, Inc.
GlaxoSmithKline Plc revealed its plan to split its businesses into two, after forming a joint venture with its U.S. rival Pfizer Inc.
Jan 1, 2018 | reuters.comFoundation Medicine, Inc. partnered with Pfizer, Inc. on Jan 16th 18'.
Foundation Medicine said today it will partner with Pfizer to develop and commercialize companion diagnostics (CDx) for the pharma giant’s oncology portfolio, through a collaboration whose value was not disclosed.
Jan 1, 2018 | genengnews.comPfizer, Inc. launched oneSCDvoice on Jan 1st 18'.
Pfizer launched oneSCDvoice in January.
Jan 1, 2018 | sicklecellanemianews.comPfizer, Inc. launches Bextra
Pfizer launched Bextra, a drug apart of the revolutionary class of painkillers known as Cox-2 inhibitors.
Jan 1, 2017 | safewhistle.comPfizer, Inc. launches system that it calls ATLAS
In fact, Pfizer has launched a new system that it calls ATLAS, with a website and a mobile app for healthcare providers to track antibiotic resistance.
Jan 1, 2017 | fiercepharma.comPfizer, Inc. had issues with patents on kidney cancer drug Sutent on Nov 15th 17'.
Pfizer execs can sigh with relief now that a federal court has backed the company's patents on kidney cancer drug Sutent.
Jan 1, 2017 | fiercepharma.comICU Medical, Inc. is planning to invest into Pfizer, Inc. in $600M cash
Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICUMedical common stock, giving the drugmaker a stake of about 16.6%.
Jan 1, 2016 | fortune.comICU Medical, Inc. sells assets to Pfizer, Inc.
As part of the transaction, Pfizer will acquire 16.6% of ICU Medical.
Jan 1, 2016 | lifesciencesipreview.comPfizer, Inc. is planning to sell assets to ICU Medical, Inc. in the amount of $1B
Pfizer Inc. (NYSE:PFE) said that, it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company
Jan 1, 2016 | benchmarkmonitor.comPfizer, Inc. sold assets to ICU Medical, Inc. in the amount of $1B on Oct 5th 16'.
The New York, Washington, DC, Los Angeles, Orange County, San Diego and London offices of Latham & Watkins LLP; Baker McKenzie LLP’s Chicago and Houston offices and Pellerano & Herrera in Santo Domingo have helped Californian medical technology company ICU Medical acquire pharma titan Pfizer’s infusion therapy business, Hospira Infusion Systems, for US$1 billion.
Jan 1, 2016 | latinlawyer.comPfizer, Inc. partners with Lung
Pfizer and the American Lung Association have ditched their celeb spokesman on a joint disease awareness push for pneumococcal pneumonia, the disease targeted by the drug giant's vaccine, Prevnar.
Jan 1, 2015 | fiercepharma.com